2024
Is yearly interferon gamma release assay latent tuberculosis infection screening warranted among patients with rheumatological diseases on disease-modifying drugs in non-endemic settings?
Palacios C, Chowdhary V, Hao R, Danve A, Malinis M. Is yearly interferon gamma release assay latent tuberculosis infection screening warranted among patients with rheumatological diseases on disease-modifying drugs in non-endemic settings? PLOS ONE 2024, 19: e0306337. PMID: 38959249, PMCID: PMC11221665, DOI: 10.1371/journal.pone.0306337.Peer-Reviewed Original ResearchConceptsInterferon-gamma release assayDisease-modifying antirheumatic drugsInterferon-gamma release assay testLatent tuberculosis infectionNon-endemic settingsRheumatologic diseasesRisk factorsPositive interferon-gamma release assayLatent tuberculosis infection screeningLatent tuberculosis infection diagnosisPositive IGRA testMonths of rifampinLow-risk patientsRetrospective chart reviewTNF-alpha inhibitorsTB risk factorsTargeted LTBI screeningOutpatient rheumatology clinicDisease-modifying drugsIGRA testPatient demographicsAdult patientsChart reviewAntirheumatic drugsNon-endemic areas
2015
Determinants of Patient Satisfaction in an Academic Rheumatology Practice
Ku JH, Danve A, Pang H, Choi D, Rosenbaum JT. Determinants of Patient Satisfaction in an Academic Rheumatology Practice. JCR Journal Of Clinical Rheumatology 2015, 21: 256-262. PMID: 26203830, DOI: 10.1097/rhu.0000000000000263.Peer-Reviewed Original ResearchConceptsPatient satisfactionCross-sectional cohort studyAcademic rheumatology practiceChronic disease managementPatient satisfaction ratingsNon-Hispanic whitesMedian satisfaction levelRheumatologic settingCohort studyPolymyalgia rheumaticaRheumatology patientsRheumatic diseasesRheumatology practiceMean ageMedical recordsFemale genderAfternoon appointmentsSatisfaction scoresOlder ageOregon HealthPhysician performancePredictors of satisfactionDisease managementPatientsRegression analysis